| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000042287 |
| Receipt No. | R000048276 |
| Scientific Title | Factual investigation of Portoplumonary hypertension in chronic liver disease |
| Date of disclosure of the study information | 2020/10/29 |
| Last modified on | 2021/02/24 (Ver. 3) |
| Basic information | ||
| Public title | Factual investigation of Portoplumonary hypertension in chronic liver disease | |
| Acronym | Factual investigation of Portoplumonary hypertension in chronic liver disease | |
| Scientific Title | Factual investigation of Portoplumonary hypertension in chronic liver disease | |
| Scientific Title:Acronym | Factual investigation of Portoplumonary hypertension in chronic liver disease | |
| Region |
|
|
| Condition | |||
| Condition | Chronic liver disease, Portoplumonary hypertension | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify the clinical course of portal hypertension and the clinical course of diagnosed portal hypertension in patients with chronic liver disease. |
| Basic objectives2 | Others |
| Basic objectives -Others | Observational study |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | the prevalence of PoPH in Japanese patients with chronic liver disease |
| Key secondary outcomes | the etiology of PoPH in Japanese patients with chronic liver disease
the overall 5-year survival rate |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients over 20 years of age who have been diagnosed with chronic liver disease in our hospital and present with clinical symptoms (e.g., chest pain, dyspnea, syncope, blood sputum, etc.) that are suspicious of PoPH.
(2) Patients diagnosed with portal hypertension who can be followed up in our hospital. |
|||
| Key exclusion criteria | (1)Cases for which follow-up was not possible at our hospital
(2) Any other cases that the researcher deems inappropriate. |
|||
| Target sample size | 2500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shinshu university | ||||||
| Division name | Department of Internal Medicine, Division of Gastroenterology | ||||||
| Zip code | 390-08621 | ||||||
| Address | 3-1-1, Asahi, Matsumoto, Japan | ||||||
| TEL | 0263-37-2634 | ||||||
| ninai@shinshu-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shinshu university | ||||||
| Division name | Department of Internal Medicine, Division of Gastroenterology | ||||||
| Zip code | 390-08621 | ||||||
| Address | 3-1-1, Asahi, Matsumoto, Japan | ||||||
| TEL | 0263-37-2634 | ||||||
| Homepage URL | |||||||
| ninai@shinshu-u.ac.jp | |||||||
| Sponsor | |
| Institute | Shinshu university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shinshu University Faculty of Medicine, Department of Gastroenterology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shinshu University Ethics Committee |
| Address | 3-1-1, Asahi, Matsumoto, Japan |
| Tel | 0263-37-2572 |
| mdrinri@shinshu-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 信州大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048276 |